secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001104659-22-086224
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical Q2 net income falls 66% to $66.3M; EPS $0.43 vs $1.22
--------------------------------------------------------------------

- Revenue $1,584.7M (+1.3% YoY); net income $66.3M vs $196.2M; diluted EPS $0.43 vs $1.22.
- Adjusted EBITDA $181.0M vs $342.0M; includes $15.1M Provider Relief Fund income (prior year $98.0M).
- Critical illness recovery hospital segment Adjusted EBITDA plunged to $20.0M from $72.9M; margin 3.7% vs 13.4%.
- Board declared $0.125/share cash dividend payable Sept 2, 2022 to holders of record Aug 16, 2022.
- Reaffirms FY2022 revenue outlook $6.25B-$6.40B; defers Adjusted EBITDA/EPS guidance until labor market stabilizes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465922086224/0001104659-22-086224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465922086224/tm2222622d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-086224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer